Changes in levels of neuromarkers and cognitive functioning of patients with treatment-resistant schizophrenia

Abstract

In this paper we analyze the changes in the blood levels of neuron-specific enolase and S100B protein during combined ECT and pharmacological treatment in patients suffering from treatment-resistant paranoid schizophrenia. Correlations between biomarkers’ serum levels, clinical status and characteristics of cognitive functioning are analyzed.

Keywords

• шизофрения
• электросудорожная терапия
• нейромаркеры
• когнитивное функционирование
• schizophrenia
• electroconvulsive therapy
• biomarkers
• cognitive functioning